enterica serovar Typhimurium of definitive phage type (DT) 104 with chromosomal integration of the genes coding for resistance to ampicillin, chloramphenicol, streptomycin, sulfonamides, and tetracycline has been previously described (12) . In Africa, the first Salmonella strains with ESBLs were identified in 1988 in Tunisia and belonged to serotype Wien (4) . In Senegal, the first multiresistant Salmonella strains with ESBL activity belonged to serotype Kentucky and were identified only in a human sample (5) .
All the strains seem to be epidemiologically related; however, an investigation has failed to prove any relationship between the animal and human isolates. Nosocomial transmission is not probable since isolation of the strains from each patient was done within the 48 h following admission to the hospital.
How has this multiresistant strain emerged? The extensive use of antimicrobial agents as feed additives for farm animals and in the control and treatment of Salmonella infection has been suggested as a predisposing factor in the evolution of multiresistant strains (2) . In Senegal, antibiotics are used extensively in the poultry industry to reduce mortality and to increase the body weight of the animals. In most of these artisan or familial farms, there is a drastic absence of adherence to measures of good farming practice and good manufacturing practice during production and processing. Contrary to practices in developed countries, a decontamination step for eliminating pathogenic microorganisms from meat has not been considered in Senegal. Additionally, poultry products are served at street food stalls or in fast-food restaurants where food processors are not always aware of food safety rules. This is the first isolation of this Salmonella serotype from animals in Senegal. There is a potential threat for the transmission of this multiresistant, ESBL-producing strain via the food chain to humans.
